Jubilant Pharmova Ltd

NSE: JUBLPHARMA · BSE: 530019 · Pharmaceuticals & Biotechnology · 29 announcements

Share price: ₹974.60
Market cap: ₹15,524 Cr
Revenue (annual): ₹8,280 Cr
Net profit (annual): ₹398.5 Cr
P/E (TTM): 44.1×Sector 47.3×
Promoter holding: 47.68%+0.00% QoQ
FII holding: 15.87%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 6 Annual General Meeting 4 Other Announcement 3 Financial Results 3 Board Meeting Outcome 3 Results Update 2 Business Update 2 Production Started 1 Management Change 1 Employee Stock Options 1 Earnings Call 1 Dividend 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

10 Aug 2026 19:15 IST BSE

Financial Results

Jubilant Pharmova Q1 FY27 Results: Net Profit ₹56.4 Cr, Down 45.0% YoY

Jubilant Pharmova Ltd reported revenue from operations of ₹2,229 Cr (+17.3% YoY) and net profit of ₹56.4 Cr (-45.0% YoY) for Q1 FY27.

Key figure: Net profit ₹56.4 Cr · -45.0% YoY

Open full results → Read the filing ↗

22 May 2026 14:26 IST BSE

Financial Results

Jubilant Pharmova Q4 FY26 Results: Net Profit ₹119.3 Cr, Down 21.2% YoY

Jubilant Pharmova Ltd reported revenue from operations of ₹2,290 Cr (+18.7% YoY) and net profit of ₹119.3 Cr (-21.2% YoY) for Q4 FY26.

Key figure: Net profit ₹119.3 Cr · -21.2% YoY

Open full results → Read the filing ↗

22 May 2026 14:26 IST BSE

Financial Results

Jubilant Pharmova Financial Results

Jubilant Pharmova reported audited FY26 financial results and recommended a 500% final dividend of ₹5 per share. Totaling ₹79.6 Crore, payment follows shareholder approval.

Value: ₹79.60 Cr

Read the filing ↗